Revenue $106.10B, up 7.3% on a year earlier. Diluted EPS $2.31 against $0.80.
| Q2 FY26 | Q1 FY26 | Q2 FY25 | Year over year | |
|---|---|---|---|---|
| Revenue | $106.10B | $100.43B | $98.92B | +7.3% |
| Operating income | $4.70B | $4.68B | $2.38B | +97.5% |
| Net income | $2.98B | $2.96B | $1.02B | +191.8% |
| Diluted EPS | $2.31 | $2.30 | $0.80 | |
| Operating cash flow | $6.34B | $4.25B | $1.90B | +234.5% |
| Capital expenditures | -$691.00M | -$849.00M | -$607.00M | |
| Free cash flow | $5.65B | $3.40B | $1.29B | +338.3% |
| Dividend per share | $0.67 | $0.67 | $0.67 |
| Q2 FY26 | Q2 FY25 | Year over year | |
|---|---|---|---|
| Pharmacy same store sales growth | 2.9% | 18.1% | |
| Front store same store sales growth | 1% | 3.4% | |
| Pharmacy Services segment total revenues | $51.80B | $46.45B | +11.5% |
| Pharmacy & Consumer Wellness segment total revenues | $33.82B | $33.58B | +0.7% |
| Pharmacy Revenue | $27.78B | $27.63B | +0.5% |
| Same-Store Sales Growth | 2.6% | 6.4% | |
| Health Care Benefits segment total revenues | $37.54B | $36.26B | +3.5% |
The week's biggest guidance misses, KPI surprises and one chart.
Stock Atlas, “CVS HEALTH (CVS) Q2 FY26 earnings: results and KPIs”, stockatlas.com/companies/CVS/earnings/2026-q2/, data as of 3 November 2026. Links to this page are welcome.
